Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
1999-12-10
2003-05-13
Eyler, Yvonne (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387900, C530S388100, C530S350000, C530S300000, C424S139100, C424S141100, C435S007100, C435S069100, C536S023100
Reexamination Certificate
active
06562949
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to semaphorin receptor polypeptides, the nucleic acids encoding such semaphorin receptor polypeptides, processes for producing recombinant semaphorin receptor polypeptides, and pharmaceutical compositions containing such polypeptides.
BACKGROUND OF THE INVENTION
The semaphorin gene family includes a large number of molecules that encode related transmembrane and secreted glycoproteins known to be neurologic regulators. The semaphorins are generally well conserved in their extracellular domains which are typically about 500 amino acids in length. Semaphorin family proteins have been observed in neuronal and nonneuronal tissue and have been studied largely for their role in neuronal growth cone guidance. For example, the secreted semaphorins known as collapsin-1 and Drosophila semaphorin II are selectively involved in repulsive growth cone guidance during development. Flies having semaphorin II genes that are mutated so that their function is reduced exhibit abnormal behavior characteristics.
Another semaphorin gene has been identified in several strains of poxvirus. This semaphorin is found in vaccinia virus (Copenhagen strain) and is encoded in an open reading frame (ORF) known as A39R. The A39R encoded protein has no transmembrane domain and no potential membrane linkage and is known to be a secreted protein. A variola virus ORF also contains sequences that share homology with the vaccinia virus ORF A39R at the nucleotide level and the amino acid level. Another viral semaphorin, AIV-sema, has been found in the Alcelaphine Herpesvirus (AHV).
Genes encoding mammalian (human, rat, and mouse) semaphorins have been identified, based upon their similarity to insect semaphorins. Functional studies of these semaphorins suggest that embryonic and adult neurons require a semaphorin to establish workable connections. Significantly, the fast response time of growth cone cultures to appropriate semaphorins suggests that semaphorin signaling involves a receptor-mediated signal transduction mechanism. To date, one semaphorin receptor, designated neuropilin, has been isolated using mRNA from rat spinal cord. Another receptor, designated neuropilin-2, has been suggested (Kolodkin et al.
Cell
90:753-762, 1997)
Semaphorin ligands that are secreted into the extracellular milieu signal through receptor bearing cells in a local and systemic fashion. In order to further investigate the nature of cellular processes regulated by such local and systemic signaling, it would be beneficial to identify additional semaphorin receptors and ligands. Furthermore, because virus encoded semaphorins are produced by infected cells and are present in viruses that are lytic (poxviruses) and viruses that are not known to be neurotropic (AHV), it is unlikely that their primary function is to modify neurologic responses. It is more likely that the virus encoded semaphorins function to modify the immunologic response of the infected host and it is likely that mammalian homologues to virus encoded semaphorins function to modify the immunologic response. In view of the suggestion that viral semaphorins may function in the immune system as natural immunoregulators it would be beneficial to identify semaphorin receptors as therapeutic agents for enhancing or downregulating the immune response.
SUMMARY OF THE INVENTION
The present invention pertains to semaphorin receptors as isolated or homogeneous proteins. In particular, the present invention provides a semaphorin receptor polypeptide, designated VESPR (Viral Encoded Semaphorin Protein Receptor) that binds semaphorins, including, but not limited to, the A39R vaccinia semaphorin and AHV semaphorin. Also, within the scope of the present invention are DNAs encoding VESPR polypeptides and expression vectors that include DNA encoding VESPR polypeptides. The present invention also includes host cells that have been transfected or transformed with expression vectors that include DNA encoding a VESPR polypeptide, and processes for producing VESPR polypeptides by culturing such host cells under conditions conducive to expression. The present invention further includes antibodies directed against VESPR polypeptides.
Further within the scope of the present invention are processes for purifying or separating semaphorins or cells that express semaphorins to which the VESPR polypeptides of the present invention bind. Such processes include binding at least one VESPR polypeptide to a solid phase matrix and contacting a mixture containing a semaphorin polypeptide to which the VESPR polypeptide binds, or a mixture of cells expressing the semaphorin with the bound VESPR polypeptide, and then separating the contacting surface and the solution.
The present invention additionally provides processes for treating inflammation and inflammatory diseases. Such processes include administering a therapeutically effective amount of a soluble VESPR polypeptide to an human or other mammal afflicted with a disease associated with proinflammatory activity of a semaphorin ligand.
REFERENCES:
patent: WO 93 16178 (1993-08-01), None
patent: WO 95 07706 (1995-03-01), None
Adams, et al., “Human Brain Expressed Sequence Tag EST01773”, Geneseq Database entry Q61322, Accession No. Q61322, Mar. 1994.
Chen, H. et al., “Neuropilin-2, a Novel Member of the Neuropilin Family, is a High Affinity Receptor for the Semaphorins Sema E and Sema IV but not Sema III”,Neuron 19: 547-559, 1997.
Comeau, et al., “A Poxvirus-Encoded Semaphorin Induces Cytokine Production from Monocytes and Binds to a Novel Cellular Semaphorin Receptor, VESPR”,Immunity 8: 473-482, Apr. 1998.
Embl-est Database Accession No. N22685, yx64c01.s1 Homo sapiens cDNA clone 2664963'. Submitted by Hillier et al., 1995.
Essner, A., et al., “Alcelaphine herpesvirus type 1 has a semaphorin-like gene”,Journal of General Virology 76:1063-1067, 1995.
George et al., Current Methods in Sequence Comparison and Analysis, selected methods and applications. Edited by David H. Schlesinger, Alan R. Liss, Inc., New York, 124-129, 1988.
Hall, K.T., et al., “Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation”,Proc. Natl. Acad. Sci. USA 93:11780-11785, 1996.
He, Z., et al., “Neuropilin is a Receptor for the Axonal Chemorepellent Semaphorin III”,Cell 90:739-751, 1997.
Kameyama, T., et al., “Identification of Plexin Family Molecules in Mice”,Biochemical and Biophysical Research Communications 226:396-402, 1996.
Kameyama, T., et al., “Identification of a Neuron Cell Surface Molecule, Plexin, in Mice”,Biochemical and Biophysical Research Communications 226:524-529, 1996.
Kolodkin, A., et al., “The Semaphorin Genes Encode a Family of Transmembrane and Secreted Growth Cone Guidance Molecules”,Cell 75:1389-1399, 1993.
Kolodkin, A.L., “Semaphorins: mediators of repulsive growth cone guidance”,Trends in Cell Biology 6: 15-22, 1996.
Kolodkin, A. L., et al., “Neuropilin is a Semaphorin III Receptor”,Cell 90:753-762, 1997.
Maestrini, E., et al., “A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor”,Proc. Natl. Acad. Sci. USA 93:674-678, 1996.
Mangasser-Stephan, K., et al., “Identification of Human Semaphorin E Gene Expression in Rheumotoid Synovial Cells by mRNA Differential Display”,Biochemical and Biophysical Research Communications 234:153-156, 1997.
Nagase, T., et al., “Prediction of the Coding Sequences of Unidentified Human Genes. VII. The Complete Sequences of 100 New cDNA Clones from Brain Which Can Code for Large Proteins in Vitro”,DNA Research 4:141-150, 1997.
Ohta, K., et al., “Plexin: A Novel Neuronal Cell Surface Molecule that Mediates Cell Adhesion via a Homophilic Binding Mechanism in the Presence of Calcium Ions”,Neuron 14:1189-1199, 1995.
Promega Protein Guide: Tips and Techniques, Promega Corporation, Madison, WI, USA, 55-66, 1993.
Satoda, M., et al., “Differential Expression of Two Cell Surface Proteins, Neuropilin aand Plexin, in Xenopus Olfactory Axon Subclasses”,Journal of Neuroscience 15:942-955, 1995.
Tessier-Lavigne
Comeau Michael R.
DuBose Robert F.
Johnson Richard S.
Spriggs Melanie K.
Basi Nirmal S.
Eyler Yvonne
Fowler Kathleen
Immunex Corporation
Jones Simone L.
LandOfFree
Antibodies to viral encoded semaphorin protein receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to viral encoded semaphorin protein receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to viral encoded semaphorin protein receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3090582